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Perspectives
Indicators that monitor health policies 
and programmes reflect the strategic 
foundations of pursued goals and guide 
interventions and are therefore critical 
to public health. Hence, using premature 
mortality (that is, deaths among people 
30–69 years of age) from selected non-
communicable diseases as an indicator 
for monitoring the health-related sus-
tainable development goal (SDG) target 
of reducing noncommunicable disease 
premature mortality by a third by 2030, 
has been disputed as being ageist and for 
focusing on only four groups of diseas-
es.1–3 Rebuttal to this criticism is based 
on assertions that premature mortality 
correlates closely with life expectancy, 
is easy to understand, is consistent with 
the World Health Assembly 2012 reso-
lution WHA65.3 on noncommunicable 
diseases, and is the global priority for 
these diseases.4
Ageism is a value set rather than an 
epidemiological concept and engenders 
attitudes that reinforce stereotypes of 
older people as frail and of low social 
and economic value. We argue that this 
health target indicator, based on the 
existing definition of premature mor-
tality, could be perceived as ageist. Our 
argument is based on ethical principles, 
recognition of the achievements of age-
based health care in wealthier countries 
and evidence of cost–effective benefits of 
prevention and treatment for noncom-
municable diseases in older people.1,3 
Furthermore, we are concerned about 
the semantic and intuitive effects of 
age-bounded definitions of premature 
mortality. Describing avoidable deaths 
from noncommunicable diseases of 
people older than 69 years of age as 
non-premature leads to reinforcement 
and justification of the ageist bias that 
often permeates the health sector. The 
article from Byass5 illustrates this ageist 
bias by showing the correlation between 
mortality rates from noncommunicable 
diseases at 30 to 69 years of age with 
those 70 to 89 years of age, and conclud-
ing that the premature mortality indica-
tor, therefore, should not be construed as 
ageist.5 Mortality rates for different age 
groups are correlated because time and 
geographic trends in noncommunicable 
disease mortality are largely due to pe-
riod effects, with cohort effects playing 
a less important role. Byass’ finding is 
not inevitable. For example, correlations 
may change as the smoking epidemic in 
low- and middle-income countries im-
pacts progressively on older age groups. 
The key difference between mortality 
rates in people younger than 70 years 
of age and those older is their increased 
order of magnitude: 3.9 per 100 000 
versus 43 per 100 000. Although the 
rates correlate, using an indicator that 
includes the age groups that have the 
major burden of disease would be better. 
The target indicator also applies a 
restricted definition of noncommuni-
cable diseases, cardiovascular disease, 
cancers, diabetes and chronic respira-
tory disease. Byass notes that this lim-
ited definition is often justified by the 
difficulty of ascertaining cause of death 
in older people.5 However, the unde-
termined causes of death by age group 
reported were actually small, 14.6% 
(4364/29 911) among those older than 
65 years of age compared with 11.5% 
(782/68 518) younger than 65 years of 
age, indicating that ascertainment of 
cause of death is not a barrier to ex-
panding the noncommunicable diseases 
included in an SDG mortality indicator.
In our analysis of cardiovascular 
disease mortality from 36 countries of 
the WHO region of the Americas, peo-
ple 70 years of age or older accounted for 
the majority of cardiovascular disease 
deaths in all these countries, ranging 
from 52.0% in the Bahamas to 80.0% in 
Canada.6 Furthermore, between 2000 
and 2015, the annual average percent-
age changes in cardiovascular disease 
mortality in Brazil, Canada, Colombia, 
Mexico and the United States of America 
generally decreased, with the exception 
of Mexico, and the largest reductions 
were observed in age groups older than 
70 years of age. The proportion of the 
population older than 70 years of age is 
estimated to double from 5.6% in 2000 
to 10.5% by 2030,7 which gives further 
motivation to use an indicator capable 
of capturing trends among older people.
Byass further justified the SDG 
indicator by stating that reducing the 
probability of noncommunicable dis-
ease deaths at older ages is less feasible 
than among those 30 to 69 years of age.5 
However, extensive evidence exists that 
many preventive and health-care inter-
ventions are of greater benefit at older 
ages in terms of absolute rate reductions 
in mortality and in cost–effectiveness.3
Noncommunicable disease 
selection
The noncommunicable disease count-
down 2030 group is concerned that the 
SDG indicator only partially captures 
global inequalities and should be more 
comprehensive and inclusive.2 The 
group has proposed using a different 
outcome alongside monitoring prog-
ress towards the related SDG target: all 
deaths in people younger than 80 years 
of age from noncommunicable diseases. 
The group’s analyses showed that annual 
time trends for the SDG indicator and 
the comprehensive noncommunicable 
disease outcome were highly corre-
lated. The SDG indicator gave a more 
optimistic picture of progress than the 
comprehensive outcome in many popu-
lations. The target will be achieved in 
35/188 countries (19%) for women, and 
30/188 (16%) for men, if these countries 
maintain or surpass their 2010–2016 
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rate of decline in noncommunicable 
disease mortality.8 If the comprehensive 
outcome were to be adopted as the in-
dicator, only 17/188 countries (9%) for 
women and 5/188 countries (3%) for 
men would be on track to reduce the 
probability of death by a third by 2030.2 
This difference is probably explained by 
the comprehensive outcome having a 
greater proportion of noncommunicable 
disease deaths that are not avertable 
by personal health care, public health 
programmes or policies.
Current indicator 
consequences
Byass further asserts that the use of this 
indicator neither involves nor implies 
any lack of care or concern for older peo-
ple.5 However, excluding older people 
from the indicator creates an incentive 
for countries with no civil registration 
and vital statistics systems and limited 
resources to prioritize collecting cause of 
death data only for those 30–69 years of 
age, which is clearly an incomplete and 
limited approach. The link between an 
SDG indicator and the relevant health-
care delivery seems obvious; if the 
former is selective, the latter will likely 
be too. Health targets are intended to 
drive health policy and services, which 
are embedded in the drive towards uni-
versal health coverage (UHC). However, 
the tracer interventions specified for 
this goal do not include any noncom-
municable disease interventions and are 
limited to targets from the millennium 
development goals (immunization, 
maternal-child health, human immu-
nodeficiency virus, tuberculosis and 
insecticide-treated bednets).8
Including tracer interventions for 
noncommunicable diseases in the UHC 
goal would improve the likelihood that 
services would be developed, and deaths 
and long-term, serious disability would 
be averted. Our inability to manage 
the societal costs of noncommunicable 
diseases in older people is now obvious 
in high-income countries. In low- and 
middle-income countries, incorporat-
ing health and social care for ageing 
populations into health policy is critical. 
A recent evaluation of SDG impacts 
concluded that all led to unintended 
consequences for other important objec-
tives and development.9 Many low- and 
middle-income countries are dependent 
on development assistance for fund-
ing health care. Such funds are largely 
spent on younger people and only 2.3% 
of these funds are directed towards 
noncommunicable diseases.10 Chronic 
diseases that typically affect older people 
receive only 0.3% of 36.4 billion United 
States dollars in 2015 of development 
funds for health. Since 1990, the funds 
for development assistance have qua-
drupled but the proportion of funding 
on noncommunicable diseases has de-
clined despite the rising burden of these 
diseases.10 Health care for older people 
with noncommunicable disease could be 
more comprehensive if international and 
national targets and indicators focused 
on matching development funding on 
the burden of disease. 
An alternative approach
Both the current indicator and the 2030 
countdown group’s approach are capable 
of generating useful data for assessing 
progress but we believe these indicators 
can be improved. Our current work has 
involved using existing lists of noncom-
municable disease causes of death that 
are either preventable through public 
health policies and interventions or 
amenable to health care to create a list 
of avertable noncommunicable disease 
causes of death, which was then mapped 
to the Global Burden of Disease (GBD) 
cause list. Age-standardized years of life 
lost (YLL) per 100 000 population due to 
avertable and non-avertable mortality 
from noncommunicable diseases causes 
by sex, location and year were estimated 
from the GBD study. Trends in age-
standardized YLL due to avertable and 
non-avertable such diseases from 1990 
to 2017 were examined to assess the 
progress of avertable mortality from 
these diseases in achieving the health 
target on noncommunicable diseases.11 
We have termed the indicator premature 
avertable mortality from noncommuni-
cable diseases – premature in relation 
to the gap between age at death and 
expected life expectancy at that age. 
Our findings are that the indicator 
fell in every WHO region and in most 
countries and territories between 1990 
and 2017. Despite these reductions, only 
the WHO Western Pacific and European 
Regions and 25 countries (most of which 
are high-income countries) are on track 
to achieve this SDG target. Since 2013, 
there has been a global slowdown in the 
reduction of premature avertable mor-
tality from noncommunicable diseases 
and a stagnation in the WHO Region of 
the Americas.
Measuring such mortality gives 
comparisons of countries’ progress in 
preventing and delaying deaths from 
conditions amenable to public health 
interventions and health care. This goal 
and measure should spur countries that 
are currently off track to re-evaluate and 
strengthen their action plans, including 
those for universal health coverage. ■
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